510(k) · Cleared
ClearedDeltaScan Monitor
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Prolira B.V. · NCG Neuropsychiatric Interpretative Electroencephalograph Assessment Aid
Cleared on Feb 2, 2023 as substantially equivalent to DEN110019 (Lexicor Medical Technology, LLC, 2013) after a 149-day review. Its family tree reaches back 1 generation to 2013. 1 later device descends from it.
- Decided
- Feb 2, 2023
- Review
- 149 days
- Class
- Class II
- Product code
- NCG
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to DEN110019 (2013). 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K251936Ceribell Delirium Monitor SystemCeribell, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | DEN110019 | Neba System | Lexicor Medical Technology, LLC | 2013 | — |
| 0 (this device) | K222680 | DeltaScan Monitor | Prolira B.V. | 2023 | — |
| +1 | K251936 | Ceribell Delirium Monitor System | Ceribell, Inc. | 2025 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NCG device
- #1 K251936 Ceribell Delirium Monitor Systemscore 12.3 · 7 generations · no Class I recall
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | DEN110019 | Neba SystemSummary page 4…Name Manufacturer De novo # NEBA system NEBA HEALTH, LLC DEN110019 IV. DEVICE DESCRIPTION Acute encephalopathy and delirium are extremely common in hospitalized patients, for exam… | 2013 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K251936 | Ceribell Delirium Monitor System | 2025 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- Of its descendants, K251936 (Ceribell, Inc., 2025) has gone furthest, with 0 descendants of its own.
How does its category compare?
All NCG devicesNCG Neuropsychiatric Interpretative Electroencephalograph Assessment Aid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · NCG
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NCG
Too few NCG 510(k)s in any year since 2007 to give a median.
Recalls per year · NCG
No recall names NCG since 2007.
Adverse event reports per year · NCG
No MAUDE report names NCG since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 1 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The DeltaScan Monitor provides the binary DeltaScan Output based on a technical index of polymorphic delta (PMD) waveshape detections made in the EEG from the bipolar Fp2 and Pz channel on adult patients (over 60 years of age) to aid in the diagnosis of acute encephalopathy. DeltaScan should only be used by a healthcare provider as a component of a complete clinical evaluation or as support for the clinician's decision to pursue further testing. The…
Read the full statement (191 words)
The DeltaScan Monitor provides the binary DeltaScan Output based on a technical index of polymorphic delta (PMD)
waveshape detections made in the EEG from the bipolar Fp2 and Pz channel on adult patients (over 60 years of age) to aid
in the diagnosis of acute encephalopathy.
DeltaScan should only be used by a healthcare provider as a component of a complete clinical evaluation or as support for
the clinician's decision to pursue further testing. The device is NOT to be used as a stand-alone method in the evaluation
or diagnosis of acute encephalopathy.
The intended patient is a hospitalized, awake adult, who is at risk of acute encephalopathy and delirium as decided by the
responsible licensed healthcare physician or a medical professional working under the responsibility of a licensed
healthcare physician.
The use environment is in hospitals:
• non-sterile environments;
• ICUs, wards, and other patient evaluation locations;
The DeltaScan Monitor is intended to be used in combination with the DeltaScan Patch (K222671) through a proprietary
connector design.
Please refer to the Instructions for Use and the Instructions for Use on the Primary packaging of the DeltaScan Patch for
more information.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K222680 · printed Nov 5, 2026
Cite this page
510(k) Report. “K222680: DeltaScan Monitor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K222680
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026